Mohamed Saber Numan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Mohamed Saber Numan has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Laëtitia Michou
Université Laval, Department of Medicine, Division of Rheumatology, CHU de Québec–Université Laval Research Center; Department of Rheumatology, CHU de Québec–Université Laval , Québec City, QC
3 shared publications - Jacques P. Brown
CHU de Québec‐Université Laval Research Centre Quebec Quebec Canada
2 shared publications Nathalie Amiable
CHU de Québec-Université Laval Research Centre, G1V 4G2, Québec, Canada
2 shared publicationsEdith Gagnon
CHU de Québec-Université Laval Research Centre, G1V 4G2, Québec, Canada
1 shared publicationJacques P Brown
CHU de Québec Research Centre, CHU de Québec-Université Laval, Quebec City, QC, Canada ; Division of Rheumatology, Department of Medicine, CHU de Québec-Université Laval, Quebec City, QC, Canada ; Department of Rheumatology, CHU de Québec-Université Laval, Quebec City, QC, Canada
1 shared publicationMariam Dessay
CHU de Québec-Université Laval Research Centre, G1V 4G2, Québec, Canada
1 shared publication
Latest Publications
- Open Access
- 1 May 2019
- Published by Elsevier in Joint Bone Spine
- Vol. 86 (3) , 373-380
Gene-environment interactions in Paget's disease of bone
- 1 May 2019
- Published by Elsevier in Joint Bone Spine
- Vol. 86 (3) , 373-380
Open AccessGene-environment interactions in Paget's disease of bone
- Open Access
- 1 January 2017
- Published by Open Access Text Pvt, Ltd. in Integrative Clinical Medicine
- Vol. 1 (2)
Ambroxol hydrochloride, a chaperone therapy for Paget's disease of bone and other common autophagy-mediated aging diseases?
OA Text is an independent open-access scientific publisher showcases innovative research and ideas aimed at improving health by linking research and practice to the benefit of society.
- 1 January 2017
- Published by Open Access Text Pvt, Ltd. in Integrative Clinical Medicine
- Vol. 1 (2)
Open AccessAmbroxol hydrochloride, a chaperone therapy for Paget's disease of bone and other common autophagy-mediated aging diseases?
OA Text is an independent open-access scientific publisher showcases innovative research and ideas aimed at improving health by linking research and practice to the benefit of society.
- Open Access
- 1 August 2015
- Published by Taylor & Francis in Drug Design, Development and Therapy
- Vol. ume 9, 4695-4707
Paget’s disease of bone: an osteoimmunological disorder?
Osteoimmunology represents a large area of research resulting from the cross talk between bone and immune systems. Many cytokines and signaling cascades are involved in the field of osteoimmunology, originating from various cell types. The RANK/receptor activator of nuclear factor Kappa-B ligand (RANKL)/osteoprotegerin (OPG) signaling has a pivotal role in osteoimmunology, in addition to proinflammatory cytokines such as tumor necrosis factor-α, interleukin (IL)-1, IL-6, and IL-17. Clinically, osteoimmunological disorders, such as rheumatoid arthritis, osteoporosis, and periodontitis, should be classified according to their pattern of osteoimmunological serum biomarkers. Paget’s disease of bone is a common metabolic bone disorder, resulting from an excessively increased bone resorption coupled with aberrant bone formation. With the exception of the cellular responses to measles virus nucleocapsid protein and the interferon-gamma signature, the exact role of the immune system in Paget’s disease of bone is not well understood. The cytokine profiles, such as the increased levels of IL-6 and the interferon-gamma signature observed in this disease, are also very similar to those observed in other osteoimmunological disorders. As a potential osteoimmunological disorder, the treatment of Paget’s disease of bone may also benefit from progress made in targeted therapies, in particular for receptor activator of nuclear factor Kappa-B ligand and IL-6 signaling inhibition.
- 1 August 2015
- Published by Taylor & Francis in Drug Design, Development and Therapy
- Vol. ume 9, 4695-4707
Open AccessPaget’s disease of bone: an osteoimmunological disorder?
Osteoimmunology represents a large area of research resulting from the cross talk between bone and immune systems. Many cytokines and signaling cascades are involved in the field of osteoimmunology, originating from various cell types. The RANK/receptor activator of nuclear factor Kappa-B ligand (RANKL)/osteoprotegerin (OPG) signaling has a pivotal role in osteoimmunology, in addition to proinflammatory cytokines such as tumor necrosis factor-α, interleukin (IL)-1, IL-6, and IL-17. Clinically, osteoimmunological disorders, such as rheumatoid arthritis, osteoporosis, and periodontitis, should be classified according to their pattern of osteoimmunological serum biomarkers. Paget’s disease of bone is a common metabolic bone disorder, resulting from an excessively increased bone resorption coupled with aberrant bone formation. With the exception of the cellular responses to measles virus nucleocapsid protein and the interferon-gamma signature, the exact role of the immune system in Paget’s disease of bone is not well understood. The cytokine profiles, such as the increased levels of IL-6 and the interferon-gamma signature observed in this disease, are also very similar to those observed in other osteoimmunological disorders. As a potential osteoimmunological disorder, the treatment of Paget’s disease of bone may also benefit from progress made in targeted therapies, in particular for receptor activator of nuclear factor Kappa-B ligand and IL-6 signaling inhibition.
- Open Access
- 17 February 2015
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 12 (2) , 2289-2305
Impact of Air Pollutants on Oxidative Stress in Common Autophagy-Mediated Aging Diseases
Atmospheric pollution-induced cellular oxidative stress is probably one of the pathogenic mechanisms involved in most of the common autophagy-mediated aging diseases, including neurodegenerative diseases such as amyotrophic lateral sclerosis (ALS), Alzheimer’s, disease, as well as Paget’s disease of bone with or without frontotemporal dementia and inclusion body myopathy. Oxidative stress has serious damaging effects on the cellular contents: DNA, RNA, cellular proteins, and cellular organelles. Autophagy has a pivotal role in recycling these damaged non-functional organelles and misfolded or unfolded proteins. In this paper, we highlight, through a narrative review of the literature, that when autophagy processes are impaired during aging, in presence of cumulative air pollution-induced cellular oxidative stress and due to a direct effect on air pollutant, autophagy-mediated aging diseases may occur.
- 17 February 2015
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 12 (2) , 2289-2305
Open AccessImpact of Air Pollutants on Oxidative Stress in Common Autophagy-Mediated Aging Diseases
Atmospheric pollution-induced cellular oxidative stress is probably one of the pathogenic mechanisms involved in most of the common autophagy-mediated aging diseases, including neurodegenerative diseases such as amyotrophic lateral sclerosis (ALS), Alzheimer’s, disease, as well as Paget’s disease of bone with or without frontotemporal dementia and inclusion body myopathy. Oxidative stress has serious damaging effects on the cellular contents: DNA, RNA, cellular proteins, and cellular organelles. Autophagy has a pivotal role in recycling these damaged non-functional organelles and misfolded or unfolded proteins. In this paper, we highlight, through a narrative review of the literature, that when autophagy processes are impaired during aging, in presence of cumulative air pollution-induced cellular oxidative stress and due to a direct effect on air pollutant, autophagy-mediated aging diseases may occur.